Home

Alec Machiels

CIK 1496687 · last filed 2026-05-14

Alec Machiels is a corporate insider who has filed 65 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for APLS, was dated May 14, 2026. Across all open-market trades the lifetime net is −$4.1M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

65

Lifetime Open-Market Net

-$4.10M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Apellis Pharmaceuticals, Inc. (APLS) Delisted Director 0 $41.03 $0 -$4.10M 55 2026-05-14
CREATIVE REALITIES, INC. (CREXW) Delisted Director 6,352 $0.00 $27 $0 2 2019-10-03

Recent Filings

65 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-14 Apellis Pharmaceuticals, Inc. (APLS) Delisted Mixed −817,250 $0 EDGAR
2026-01-05 Apellis Pharmaceuticals, Inc. (APLS) Delisted Grant (A) +7,961 $0 EDGAR
2025-01-03 Apellis Pharmaceuticals, Inc. (APLS) Delisted Grant (A) +6,267 $0 EDGAR
2024-01-02 Apellis Pharmaceuticals, Inc. (APLS) Delisted Grant (A) +3,341 $0 EDGAR
2023-11-20 Apellis Pharmaceuticals, Inc. (APLS) Delisted Mixed — -$56.3K EDGAR
2023-11-17 Apellis Pharmaceuticals, Inc. (APLS) Delisted Notice (144) −1,250 -$59.7K EDGAR
2023-10-18 Apellis Pharmaceuticals, Inc. (APLS) Delisted Mixed — -$57.3K EDGAR
2023-10-17 Apellis Pharmaceuticals, Inc. (APLS) Delisted Notice (144) −1,250 -$60.6K EDGAR
2023-09-19 Apellis Pharmaceuticals, Inc. (APLS) Delisted Mixed — -$52.9K EDGAR
2023-09-18 Apellis Pharmaceuticals, Inc. (APLS) Delisted Notice (144) −1,250 -$56.2K EDGAR
Showing 1–10 of 65
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.